Table 4 Histopathologic results of IgG positive patient subgroup
IgG (+) | IgG (++) | IgG (+++) | p | |
|---|---|---|---|---|
Total glomerulus number | 18 ± 10 | 18 ± 12 | 22 ± 10 | NS |
Global sclerotic glomerulus number | 4 ± 4 | 4 ± 5 | 5 ± 3 | NS |
Segmental sclerotic glomerulus number | 2 ± 3 | 2 ± 3 | 2 ± 2 | NS |
Cellular crescent number | 1 ± 2 | 1 ± 2 | 2 ± 4 | NS |
Basal membrane thickening | 25.8% | 17.6% | 25.0% | NS |
Mesangial proliferation | 86.7% | 82.8% | 91.6% | NS |
Endocapillary proliferation | 22.8% | 24.1% | 42.8% | NS |
Interstitial inflammation | 71.3% | 71.4% | 81.8% | NS |
Tubular atrophy/interstitial fibrosis | ||||
T0 | 62.5% | 52.8% | 50.0% | NS |
T1 | 30.5% | 42.8% | 33.3% | NS |
T2 | 7% | 4.9% | 66.7% | NS |
IgA staining | ||||
(+) | 6.1% | 0% | 19.1% | NS |
(++) | 28.7% | 27.7% | 9.2% | NS |
(+++) | 65.2% | 62.3% | 72.7% | NS |
Mesangial hypercellularity | ||||
M0 | 26.7% | 14.2% | 16.6% | NS |
M1 | 73% | 85.8% | %83.4% | NS |
Endocapillary hypercellularity | ||||
E0 | 66.1 | 71.4 | 50.0% | NS |
E1 | 33.9% | 28.6% | 50.0% | NS |
Segmental glomerulosclerosis | ||||
S0 | %45.0% | 38.0 | 66.6 | NS |
S1 | %55.0% | 62.0 | 33.4 | NS |